| VIRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the VIRX shares outstanding history going back to 2/25/2021:
Also see: VIRX Market Cap History VIRX YTD Return |
As of 11/11/2024 Viracta Therapeutics has 39.74 million VIRX shares outstanding. Investors often track the VIRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VIRX share count trends over time, with 16 historical shares outstanding datapoints presented, dating back to 2/25/2021.

| VIRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the VIRX shares outstanding history going back to 2/25/2021:
Also see: VIRX Market Cap History VIRX YTD Return |
| VIRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||
VIRX Historical Shares Outstanding: +1.95% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| VIRX Stock Price Chart |
| About Viracta Therapeutics Inc |
| Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on treating and preventing virus-associated cancers. Its lead product, Nana-val, combines nanatinostat and valganciclovir. Nana-val is being tested in several clinical trials, including a Phase II trial for relapsed or refractory Epstein-Barr virus-positive (EBV+) lymphoma (NAVAL-1) and a Phase Ib/II trial for recurrent or metastatic EBV+ nasopharyngeal carcinoma and other advanced EBV+ solid tumors. Viracta is also exploring its Kick and Kill approach for other virus-related cancers. We show 16 historical shares outstanding datapoints in our coverage of VIRX's shares outstanding history. Understanding the changing numbers of VIRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VIRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VIRX by allowing them to research VIRX shares outstanding history as well as any other stock in our coverage universe. |
| VIRX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VIRX Share Performance |
| Shares Outstanding Peers |
| Viracta Therapeutics (VIRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VIVE Shares Outstanding History VIVK Shares Outstanding History VIVO Shares Outstanding History VIVS Shares Outstanding History VKTX Shares Outstanding History VLON Shares Outstanding History VLRX Shares Outstanding History VNDA Shares Outstanding History VOR Shares Outstanding History VRAY Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.